Oncology Institute
TOITOI · Stock Price
Historical price data
Overview
The Oncology Institute's mission is to redefine community-based cancer care by shifting from volume-driven to value-based reimbursement, improving outcomes and affordability. Its key achievement is building an integrated network offering medical oncology, hematology, radiation, and supportive services, underpinned by a robust clinical research program that brings trials to local communities. The core strategy involves leveraging data analytics and care coordination to succeed in risk-bearing contracts with payers, while expanding its geographic footprint and service capabilities. As a public company, it aims to demonstrate that its model can sustainably lower the total cost of cancer care while maintaining quality and access.
Technology Platform
An integrated operational and data analytics platform combining EHR, practice management, and proprietary analytics tools for risk stratification, care coordination, and performance reporting, enabling success in value-based care contracts.
Opportunities
Risk Factors
Competitive Landscape
TOI competes with hospital-owned practices, independent community oncologists, national oncology chains like US Oncology Network, and academic medical centers. Its differentiation lies in its pure focus on value-based contracts, integrated care model, and proprietary data analytics for risk management.